Kenvue, the proprietor of well-known brands such as Band-Aid, Benadryl and Tylenol, was named in a federal putative securities class action over the company’s initial public offering.

The class action complaint, Autrey v. Kenvue, first surfaced by Law.com Radar, was filed Nov. 16 in U.S. District Court for the District of New Jersey by Robert James Autrey over his purchase of shares of the company in an IPO.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]